Introduction
Welcome to Heristar—a trailblazing leader in non-invasive prenatal screening since 2019. Heristar provides all-in-one testing kits for next-generation non-invasive prenatal screening, capable of detecting over 80 severe aneuploidies, microdeletions/duplications, and monogenic disorders.
At Heristar, we offer comprehensive wet and dry lab solutions that expand your testing capabilities while reducing operational costs and enhancing test performance. With Heristar, you gain access to cutting-edge technology and meticulous support, designed to empower healthcare professionals and expectant parents alike.
Company
Heristar develops innovative technologies for the next-generation clinical testing in the field of maternal-fetal medicine.
People
Ph.D. scientists with extensive experience in molecular biology, genomics and biochemistry dedicated to clinical testing developments.
Products
Heristar develops innovative technologies for the next-generation clinical testing in the field of maternal-fetal medicine.
Our Mission
We provide the most comprehensive and accurate prenatal screening using innovative technologies for next generations.
Our Vision
We assist people make better decisions through DNA decoding.
Our Value
We seek facts, bring innovations, strive for quality and care for others.
Prospects
Heristar clients
Credentials
CLIA Certificate of Registration
Heristar stands ready to deliver unparalleled healthcare services, fortified by unwavering regulatory compliance and a steadfast commitment to excellence.
Certifications of Our Team
Laboratory Director:
-
Clinical Biochemical Genetics, American Board of Medical Genetics
-
Clinical Molecular Genetics, American Board of Medical Genetics
Medical Technologist:
-
Technologist in Molecular Biology, American Society for Clinical Pathology
